Kardiyologlar için DeepSearch/DeepResearch konuşacağımız Webinarımıza bekleriz. Erhan Meydan'dan derin araştırma tecrübelerini dinleyeceğiz.

Taylan Akgün Digital Cardiology Association Selim Topcu, MD, PhD Süleyman Çağan Efe Murat Çap, MD Aslan erdoğan

LLM, CNN (i.e. ECG-focused), and clinical prediction models (CPM, i.e. mortality risk) all pursue the same aim: highly reliable predictions—next token, ECG class, or mortality risk. Despite different labels, i think their underlying techniques are strikingly alike. 1/

C. Michael Gibson MD ALASCCA provides a powerful, hypothesis-confirming signal that warrants serious consideration in shared decision-making for ideal patients, but its statistical fragility and poor generalizability mean it does not establish a new standard of care medium.com/@haliltanboga/…

I have a Q regarding the choice of the primary endpoint in the MAPLE-HCM trial. I do believe these drugs work in HCM. However, in MAPLE-HCM, could the selection of the primary endpoint (peak VO2) have introduced bias? Because it is already known that beta-blockers can reduce